Health
1 read
New UT Cancer Drug Manipulates Immune Response to Target Tumors

Want the full story?
Read the complete article at KTSM
AI Summary
Researchers at the University of Texas have developed an innovative cancer drug that alters the immune system's response, enabling it to treat tumors as if they were viral infections. This experimental treatment aims to enhance the body's natural defenses against cancer cells, which have been shown to mimic viral infections. The implications of this breakthrough could significantly improve treatment options for cancer patients, potentially leading to more effective therapies with fewer side effects. The ongoing research highlights the importance of understanding the immune response in cancer treatment.
cancer health research ut immune-system
People & Organizations
University of Texas